56 results match your criteria: "Hull and York Medical School[Affiliation]"

The prognosis of metastatic esophageal cancer (EC) remains poor with an average life expectancy of around 9-12 months with standard systemic chemotherapy. The concept of oligometastatic disease (OMD) in EC cancer is controversial with no universally accepted definition. From the original cohort of metastatic oesophago-gastric (OG) cancer patients, 4 cases were identified that developed unusually favourable outcome with long-term survival and probable cure.

View Article and Find Full Text PDF

Background: Globally, 350 million under-5s do not have adequate childcare. This may damage their health and development and undermine societal and economic development. Rapid urbanization is changing patterns of work, social structures, and gender norms.

View Article and Find Full Text PDF

Background: The concept of oligometastatic disease (OMD) was first introduced in 1995 by Hellman and Weichselbaum and described as stage of transition between localized and widespread metastatic disease. The presence of OMD in esophagogastric (OG) cancer remains controversial. Historically, most experts believe that OG cancer is systemic disease from the outset.

View Article and Find Full Text PDF

Background: Platelets contain high levels of amyloid β (Aβ) peptides and have been suggested to participate in the deposition of amyloid plaques in Alzheimer's Disease (AD).

Objectives: This study aimed to determine whether human platelets release pathogenic Aβ peptides Aβ and Aβ and to characterise the mechanisms regulating this phenomenon.

Methods And Results: Enzyme-linked immunosorbent assays (ELISAs) revealed that the haemostatic stimulus thrombin and the pro-inflammatory molecule lipopolysaccharide (LPS) induce platelet release of both Aβ and Aβ.

View Article and Find Full Text PDF

We are in a competitive, burgeoning market for journals and currently in a transition to open access publications, with the aim of making research more widely accessible. Where is the place for practice-based journals in this new and evolving world of publishing? The recent growth of CAMH in terms of Impact Factor, downloads and submissions suggests there is a need for such journals. Professionals are swamped with research findings, often contradictory, sometimes inflammatory, with little time to explore the meaning of these findings within the real world.

View Article and Find Full Text PDF

The amyloid peptide β disrupts intercellular junctions and increases endothelial permeability in a NADPH oxidase 1-dependent manner.

Redox Biol

June 2022

Institute for Clinical Chemistry and Laboratory Medicine, University Medical Center Eppendorf (UKE), Hamburg, Germany; Centre for Atherothrombosis and Metabolic Disease (CAM), Hull and York Medical School (HYMS), Hull, UK. Electronic address:

Alzheimer's disease is the most common form of dementia and is associated with the accumulation of amyloid peptide β in the brain parenchyma. Vascular damage and microvascular thrombosis contribute to the neuronal degeneration and the loss of brain function typical of this disease. In this study, we utilised a murine model of Alzheimer's disease to evaluate the neurovascular effects of this disease.

View Article and Find Full Text PDF

During the COVID-19 pandemic, semi-structured interviews were undertaken with 20 adults awaiting a diagnosis for their chronic breathlessness. Three key themes were identified using thematic analysis: (1) de-prioritisation of diagnosis, (2) following UK 'lockdown' guidance for the general population but patients fearful they were more at risk, and (3) the impact of lockdown on coping strategies for managing breathlessness. The existing unpredictable pathway to diagnosis for those with chronic breathlessness has been further interrupted during the COVID-19 pandemic.

View Article and Find Full Text PDF

Aims And Objectives: To determine the clinical effectiveness and safety of the Orve + wrap® thermal blanket.

Background: Inadvertent perioperative hypothermia is a common problem in postanaesthetic care units and can have significant effects on patients' postoperative morbidity. Despite its commercial availability, there is no clinical evidence on the effectiveness of Orve + wrap®.

View Article and Find Full Text PDF

A Rare Case of Spinal Mastocytosis Presenting as an Extradural Mass.

World Neurosurg

January 2020

Department of Neurosurgery, Hull Royal Infirmary, Hull, UK.

Background: Systemic mastocytosis is a hematopoietic disorder of mast cell deposits in various systemic tissues that can include skin, spleen, liver, and bone marrow. When accumulation occurs within bone it has been reported to cause osteoporosis, osteosclerosis, or sometimes a mixed pattern. In exceptionally rare circumstances, it has been reported to present as an exophytic mass causing neural compression.

View Article and Find Full Text PDF

Background: The Ottawa score was previously developed to predict recurrent venous thromboembolism (VTE) in cancer patients with VTE. The performance of this score in patients with incidental VTE is currently unclear.

Aim: To evaluate the performance of the Ottawa risk score in cancer patients with incidental pulmonary embolism included in an international, prospective, observational cohort study.

View Article and Find Full Text PDF

Background: Insight into health conditions associated with death can inform healthcare policy. We aimed to cluster 27,525,663 deceased people based on the health conditions associated with death to study the associations between the health condition clusters, demographics, the recorded underlying cause and place of death.

Methods: Data from all deaths in the United States registered between 2006 and 2016 from the National Vital Statistics System of the National Center for Health Statistics were analyzed.

View Article and Find Full Text PDF

Purpose: Pulmonary embolism is incidentally diagnosed in up to 5% of patients with cancer on routine imaging scans. The clinical relevance and optimal therapy for incidental pulmonary embolism, particularly distal clots, is unclear. The aim of the current study was to assess current treatment strategies and the long-term clinical outcomes of incidentally detected pulmonary embolism in patients with cancer.

View Article and Find Full Text PDF

Time to eradicate HTLV-1: an open letter to WHO.

Lancet

May 2018

HTLV-1 Task Force, Global Virus Network, Baltimore, MD, USA; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, USA.

View Article and Find Full Text PDF

Correction to: British Society of Interventional Radiology (BSIR) Inferior Vena Cava (IVC) Filter Registry.

Cardiovasc Intervent Radiol

April 2018

Hull and York Medical School, University of York, John Hughlings Jackson Building, Heslington, York, YO10 5DD, UK.

On page 1553, the caption on Table 1 should read: Retrieval of filter by filter make/model and % retrievals within the manufacturer timescale.

View Article and Find Full Text PDF

A bias-adjusted evidence synthesis of RCT and observational data: the case of total hip replacement.

Health Econ

February 2017

Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT-University for Health Sciences, Medical Informatics and Technology, Eduard Wallnoefer Center I, Hall i.T., Austria.

Evaluation of clinical effectiveness of medical devices differs in some aspects from the evaluation of pharmaceuticals. One of the main challenges identified is lack of robust evidence and a will to make use of experimental and observational studies (OSs) in quantitative evidence synthesis accounting for internal and external biases. Using a case study of total hip replacement to compare the risk of revision of cemented and uncemented implant fixation modalities, we pooled treatment effect estimates from OS and RCTs, and simplified existing methods for bias-adjusted evidence synthesis to enhance practical application.

View Article and Find Full Text PDF

Reporting Guidelines for the Use of Expert Judgement in Model-Based Economic Evaluations.

Pharmacoeconomics

November 2016

Manchester Centre for Health Economics, The University of Manchester, 4th Floor, Jean McFarlane Building, Oxford Road, Manchester, M13 9PL, UK.

Introduction: Expert judgement has a role in model-based economic evaluations (EEs) of healthcare interventions. This study aimed to produce reporting criteria for two types of study design to use expert judgement in model-based EE: (i) an expert elicitation (quantitative) study; and (ii) a Delphi study to collate (qualitative) expert opinion.

Methods: A two-round online Delphi process identified the degree of consensus for four core definitions (expert; expert parameter values; expert elicitation study; expert opinion) and two sets of reporting criteria in a purposive sample of experts.

View Article and Find Full Text PDF

Background: Home tele-monitoring (HTM) is used to monitor the clinical signs and symptoms of patients with chronic heart failure (CHF) in order to reduce unplanned hospital admissions. However, not all patients who are referred will agree to use HTM, and some patients choose to withdraw early from its use.

Aims: ADaPT-HF will investigate whether depression, anxiety, low perceived control, reduced technology capability, level of education, age or the severity or complexity of a patient's illness can predict refusal of, or early withdrawal from, HTM in patients with CHF.

View Article and Find Full Text PDF

The effectiveness and safety of two prophylactic antibiotic regimes in hip-fracture surgery.

Eur J Orthop Surg Traumatol

July 2016

Department of Trauma and Orthopaedic Surgery, Hull Royal Infirmary, Hull, UK.

Antibiotic prophylaxis with cefuroxime can reduce the incidence of deep wound infection (DWI) in hip-fracture surgery, but may increase the risk of C. difficile infection (CDI). An alternative is gentamicin with beta-lactam for which a question exists around clinical effectiveness and safety, given the gentamicin-associated nephrotoxicity particularly in the elderly and narrower sensitivity spectrum.

View Article and Find Full Text PDF

Self-expandable metal stent placement for malignant duodenal obstruction distal to the bulb.

Eur J Gastroenterol Hepatol

December 2015

aDepartment of Radiology, Castle Hill Hospital, Hull and East Yorkshire NHS Trust, Cottingham bThe Queen's Centre for Oncology and Haematology, Hull and York Medical School, Castle Hill Hospital, Hull, UK cDepartment of Diagnostic Radiology, The University of Hong Kong, Queen Mary Hospital, Hong Kong.

Objective: Self-expandable metal stents (SEMS) are widely used for the palliative management of malignant proximal gastroduodenal obstruction because of its low morbidity and mortality rates compared with surgical bypass. However, stent placement for duodenal obstruction beyond the first part of the duodenum is considered technically difficult and is not routinely performed. We report our experience with SEMS placement for these patients.

View Article and Find Full Text PDF

Purpose: We report the outcomes of patients treated with palliative radiotherapy (pRT) to the primary tumour in the context of well-controlled metastatic disease after initial chemotherapy.

Materials And Methods: Clinical records of 132 patients with metastatic esophago-gastric (OG) cancer treated with palliative chemotherapy (pCT) between January 2009 and June 2013 were reviewed. Ninetyseven patients had responding or stable disease after 3 months of chemotherapy, of whom 53 patients received pRT to the primary tumour after initial chemotherapy in the presence of well-controlled metastatic disease (group A, pCT-RT).

View Article and Find Full Text PDF

Background: Recognising dying remains a difficult clinical skill which has gained increasing importance in the United Kingdom since the Neuberger review. Clinical and research methods exist to aid recognition of dying but do not exhibit the level of accuracy required for such an important decision.

Aim: To explore change in key clinical parameters as cancer patients near the end of life.

View Article and Find Full Text PDF

Inflammatory manifestations of HTLV-1 and their therapeutic options.

Expert Rev Clin Immunol

November 2014

Department of Biology, Hull and York Medical School, Center for Immunology and Infection, University of York, YO10 5DD, UK.

Human T lymphotropic virus type 1 (HTLV-1) is one of the most intriguing retroviruses infecting humans. Most commonly, infection remains undetected, since it does not cause obvious harm, yet in 4-9% of patients, this infection can be devastating, causing adult T-cell leukemia/lymphoma and/or HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). This review concentrates on all inflammatory aspects of HTLV-1 infection: HAM/TSP, HTLV-1 associated uveitis, HTLV-1 associated conjunctivitis, sicca syndrome and interstitial keratitis, HTLV-1 associated Sjögren's syndrome, Hashimoto's thyroiditis and Graves' disease, HTLV-1 associated pulmonary disease, infective dermatitis associated with HTLV-1, HTLV-1 associated inflammatory myositis and HTLV-1 associated arthritis.

View Article and Find Full Text PDF

Mortality and missed opportunities along the pathway of care for ST-elevation myocardial infarction: a national cohort study.

Eur Heart J Acute Cardiovasc Care

June 2015

Centre for Epidemiology and Biostatistics, University of Leeds, UK Department of Cardiology, York Teaching Hospital, UK

Aims: To examine the association between cumulative missed opportunities for care (CMOC) and mortality in patients with ST-elevation myocardial infarction (STEMI).

Methods: A cohort study of 112,286 STEMI patients discharged from hospital alive between January 2007 and December 2010, using data from the Myocardial Ischaemia National Audit Project (MINAP). A CMOC score was calculated for each patient and included: pre-hospital ECG, acute use of aspirin, timely reperfusion, prescription at hospital discharge of aspirin, thienopyridine inhibitor, ACE-inhibitor (or equivalent), HMG-CoA reductase inhibitor and β-blocker, and referral for cardiac rehabilitation.

View Article and Find Full Text PDF

Clinical trials in patients with heart failure and preserved left ventricular ejection fraction.

Heart Fail Clin

July 2014

Department of Cardiology, Castle Hill Hospital, Hull and York Medical School, University of Hull, Kingston-upon-Hull, UK.

There is no robust evidence that any treatment can modify the natural history of patients with heart failure and preserved left ventricular ejection fraction (HFpEF), although most agree that diuretics can control congestion and improve symptoms. HFpEF is often complicated by systemic and pulmonary hypertension, atrial fibrillation, obesity, chronic lung and kidney disease, lack of physical fitness, and old age that can complicate both diagnosis and management. Further trials should phenotype patients precisely and create better definitions of HFpEF based on biomarkers.

View Article and Find Full Text PDF